90 related articles for article (PubMed ID: 10770092)
1. Changes of hemostatic factors in patients with hemoglobinopathies.
Oner AF; Gürgey A; Okur H; Kirazli S; Gümrük F; Altay C
Turk J Pediatr; 1999; 41(3):323-7. PubMed ID: 10770092
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.
Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Chuncharunee S; Tiraganjana A; Rattanasiri S
Am J Hematol; 2007 Nov; 82(11):1001-4. PubMed ID: 17654509
[TBL] [Abstract][Full Text] [Related]
3. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
4. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
5. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia.
Del Vecchio GC; Nigro A; Giordano P; Schettini F; Altomare M; Pietrapertosa A; De Mattia D
Acta Haematol; 2007; 118(3):136-40. PubMed ID: 17804900
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic alterations in beta-thalassemia/hemoglobin E patients.
Opartkiattikul N; Tatsumi N; Funahara Y; Shirahata A; Wongtiraporn W; Tientadakul P; Fucharoen S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():86-9. PubMed ID: 10926266
[TBL] [Abstract][Full Text] [Related]
7. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
[TBL] [Abstract][Full Text] [Related]
8. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
10. [Tendency to thrombosis following bone marrow transplantation?].
Tsakiris DA; Huser B; Gratwohl A; Marbet GA
Schweiz Med Wochenschr; 1991 Mar; 121(10):341-3. PubMed ID: 1902984
[TBL] [Abstract][Full Text] [Related]
11. Serum erythropoietin levels in thalassemia major and intermedia.
Chaisiripoomkere W; Jootar S; Chanjarunee S; Ungkanont A
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):786-8. PubMed ID: 10928378
[TBL] [Abstract][Full Text] [Related]
12. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
[TBL] [Abstract][Full Text] [Related]
13. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P
Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036
[TBL] [Abstract][Full Text] [Related]
14. Hypercoagulable state in five thalassemia intermedia patients.
Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
16. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
18. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
19. Protein C and protein S deficiency in thalassemic patients.
Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
[TBL] [Abstract][Full Text] [Related]
20. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
